This stock is not for the timid. Buy when no one is and Sell when everyone's buying. This stock has to reach a point of equilibrium and base a few days. It's been gradually selling off from $1.70's to .455 to .023 and has had several nice bounces into the .07's. Institutions and large shareholders have taken a beating on paper. It would be prudent for them to average down but then again, who knows what their particular set of circumstances is?
I believe INNMF has more dry powder left and once this heads back through .06 it will be chased once again.
They have nearly $6,000,000 in cash reserves and the clinical study has not been halted. We'll be getting updates within the next month and volume will re-enter.
Right now INNMF's experiencing an oversold base building event similar to a blood tranfusion. Old shareholders that just cant take the pain any longer, have thrown in the towel and new investors are picking up the pieces.
I've been actively trading the shares and am now building a position for the next leg sideways to up.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM